Talk:Serotonin–norepinephrine reuptake inhibitor
This is the talk page for discussing improvements to the Serotonin–norepinephrine reuptake inhibitor article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: Index, 1Auto-archiving period: 6 months ![]() |
![]() | A fact from Serotonin–norepinephrine reuptake inhibitor appeared on Wikipedia's Main Page in the Did you know column on 2 May 2004. The text of the entry was as follows:
| ![]() |
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | The contents of the Discovery and development of dual serotonin and norepinephrine reuptake inhibitors page were merged into Serotonin–norepinephrine reuptake inhibitor on 2014-03-05. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
Wiki Education assignment: Psychology Capstone
[edit] This article was the subject of a Wiki Education Foundation-supported course assignment, between 26 August 2024 and 6 December 2024. Further details are available on the course page. Student editor(s): SFronduti (article contribs). Peer reviewers: Makylam18, Carolinedean31, Sarah3102, Anlntph, Matthewpalmer03.
— Assignment last updated by Aronov13 (talk) 03:30, 6 October 2024 (UTC)
Adding information to 'special populations' section providing more in-depth detail for each category and further citations. SFronduti (talk) 02:20, 20 October 2024 (UTC)
Removed "migraine prevention" from Intro. Latest research from 2018 shows that data does not show sufficient effectiveness in prevention. See C. Sialakis, P. Antoniou. The effect of the selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors in prevention of the tension type headache and migraine: overview of Cochrane and non-Cochrane reviews. Scientific Chronicles 2018; 23(3): 288-302 eoi: http://eoi.citefactor.org/10.11212/exronika/2018.3.4 SFronduti (talk) 05:10, 10 November 2024 (UTC)